Receptor Protein Tyrosine Phosphatase-Receptor Tyrosine Kinase Substrate Screen Identifies EphA2 as a Target for LAR in Cell Migration

REFERENCES

• Soulsby M, Bennett AM. 2009. Physiological signaling specificity by protein tyrosine phosphatases. Physiology (Bethesda) 24:281–289.
   PubMed Web of Science ®Google Scholar
• Tonks NK. 2006. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7:833–846.
   PubMed Web of Science ®Google Scholar
• Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544–1548.
   PubMed Web of Science ®Google Scholar
• Bentires-Alj M, Neel BG. 2007. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Res. 67:2420–2424.
   PubMed Web of Science ®Google Scholar
• Chan G, Kalaitzidis D, Neel BG. 2008. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev. 27:179–192.
   PubMed Web of Science ®Google Scholar
• Julien SG, Dube N, Hardy S, Tremblay ML. 2011. Inside the human cancer tyrosine phosphatome. Nat. Rev. Cancer 11:35–49.
   PubMed Web of Science ®Google Scholar
• Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB. 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20:5479–5489.
   PubMed Web of Science ®Google Scholar
• Ostman A, Hellberg C, Bohmer FD. 2006. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 6:307–320.
   PubMed Web of Science ®Google Scholar
• Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. 2004. Protein tyrosine phosphatases in the human genome. Cell 117:699–711.
   PubMed Web of Science ®Google Scholar
• Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Moller NP. 2001. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell. Biol. 21:7117–7136.
   PubMed Web of Science ®Google Scholar
• Bixby JL. 2001. Ligands and signaling through receptor-type tyrosine phosphatases. IUBMB Life 51:157–163.
   PubMed Web of Science ®Google Scholar
• den Hertog J, Ostman A, Bohmer FD. 2008. Protein tyrosine phosphatases: regulatory mechanisms. FEBS J. 275:831–847.
   PubMed Web of Science ®Google Scholar
• Jiang G, den Hertog J, Hunter T. 2000. Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface. Mol. Cell. Biol. 20:5917–5929.
   PubMedGoogle Scholar
• Toledano-Katchalski H, Tiran Z, Sines T, Shani G, Granot-Attas S, den Hertog J, Elson A. 2003. Dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon. Mol. Cell. Biol. 23:5460–5471.
   PubMedGoogle Scholar
• Bilwes AM, den Hertog J, Hunter T, Noel JP. 1996. Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature 382:555–559.
   PubMed Web of Science ®Google Scholar
• Jiang G, den Hertog J, Su J, Noel J, Sap J, Hunter T. 1999. Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha. Nature 401:606–610.
   PubMedGoogle Scholar
• Felberg J, Johnson P. 1998. Characterization of recombinant CD45 cytoplasmic domain proteins. Evidence for intramolecular and intermolecular interactions. J. Biol. Chem. 273:17839–17845.
   PubMedGoogle Scholar
• Streuli M, Krueger NX, Thai T, Tang M, Saito H. 1990. Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J. 9:2399–2407.
   PubMed Web of Science ®Google Scholar
• Blanchetot C, den Hertog J. 2000. Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs. J. Biol. Chem. 275:12446–12452.
   PubMedGoogle Scholar
• Blanchetot C, Tertoolen LG, Overvoorde J, den Hertog J. 2002. Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases. J. Biol. Chem. 277:47263–47269.
   PubMedGoogle Scholar
• Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141:1117–1134.
   PubMed Web of Science ®Google Scholar
• Li S, Depetris RS, Barford D, Chernoff J, Hubbard SR. 2005. Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase. Structure 13:1643–1651.
   PubMedGoogle Scholar
• Kulas DT, Goldstein BJ, Mooney RA. 1996. The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases. J. Biol. Chem. 271:748–754.
   PubMed Web of Science ®Google Scholar
• Kulas DT, Zhang WR, Goldstein BJ, Furlanetto RW, Mooney RA. 1995. Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR. J. Biol. Chem. 270:2435–2438.
   PubMed Web of Science ®Google Scholar
• Chabot C, Spring K, Gratton JP, Elchebly M, Royal I. 2009. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Mol. Cell. Biol. 29:241–253.
   PubMedGoogle Scholar
• Debnath J, Muthuswamy SK, Brugge JS. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30:256–268.
   PubMed Web of Science ®Google Scholar
• Lee H, Gaughan JP, Tsygankov AY. 2008. c-Cbl facilitates cytoskeletal effects in v-Abl transformed fibroblast through Rac1- and Rap1-mediated signaling. Int. J. Biochem. Cell Biol. 40:1930–1943.
   PubMedGoogle Scholar
• Lee H, Tsygankov AY. 2010. c-Cbl regulates glioma invasion through matrix metalloproteinase 2. J. Cell. Biochem. 111:1169–1178.
   PubMed Web of Science ®Google Scholar
• Mercan F, Lee H, Kolli S, Bennett AM. 2013. Novel role for SHP-2 in nutrient-responsive control of S6 kinase 1 signaling. Mol. Cell. Biol. 33:293–306.
   PubMedGoogle Scholar
• Jaskolski F, Mulle C, Manzoni OJ. 2005. An automated method to quantify and visualize colocalized fluorescent signals. J. Neurosci. Methods 146:42–49.
   PubMedGoogle Scholar
• Frangioni JV, Neel BG. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210:179–187.
   PubMed Web of Science ®Google Scholar
• Mercan F, Bennett AM. 2010. Analysis of protein tyrosine phosphatases and substrates. Curr. Protoc. Mol. Biol. 91:18.16.1–18.16.17. doi:10.1002/0471142727.mb1816s91.
   Google Scholar
• Shintani T, Ihara M, Sakuta H, Takahashi H, Watakabe I, Noda M. 2006. Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O. Nat. Neurosci. 9:761–769.
   PubMedGoogle Scholar
• Ahmad F, Considine RV, Goldstein BJ. 1995. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J. Clin. Invest. 95:2806–2812.
   PubMedGoogle Scholar
• Niu XL, Li J, Hakim ZS, Rojas M, Runge MS, Madamanchi NR. 2007. Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury. J. Biol. Chem. 282:19808–19819.
   PubMedGoogle Scholar
• Parri M, Buricchi F, Taddei ML, Giannoni E, Raugei G, Ramponi G, Chiarugi P. 2005. EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase. J. Biol. Chem. 280:34008–34018.
   PubMed Web of Science ®Google Scholar
• Flint AJ, Tiganis T, Barford D, Tonks NK. 1997. Development of “substrate-trapping” mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. U. S. A. 94:1680–1685.
   PubMed Web of Science ®Google Scholar
• Tiganis T, Bennett AM. 2007. Protein tyrosine phosphatase function: the substrate perspective. Biochem. J. 402:1–15.
   PubMed Web of Science ®Google Scholar
• Fang WB, Brantley-Sieders DM, Hwang Y, Ham AJ, Chen J. 2008. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase. J. Biol. Chem. 283:16017–16026.
   PubMedGoogle Scholar
• Miao H, Burnett E, Kinch M, Simon E, Wang B. 2000. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat. Cell Biol. 2:62–69.
   PubMed Web of Science ®Google Scholar
• Holland SJ, Gale NW, Gish GD, Roth RA, Songyang Z, Cantley LC, Henkemeyer M, Yancopoulos GD, Pawson T. 1997. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J. 16:3877–3888.
   PubMed Web of Science ®Google Scholar
• Hu T, Shi G, Larose L, Rivera GM, Mayer BJ, Zhou R. 2009. Regulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1. Biochemistry 48:6369–6378.
   PubMedGoogle Scholar
• Miura K, Nam JM, Kojima C, Mochizuki N, Sabe H. 2009. EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts. Mol. Biol. Cell 20:1949–1959.
   PubMedGoogle Scholar
• Stein E, Huynh-Do U, Lane AA, Cerretti DP, Daniel TO. 1998. Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase. J. Biol. Chem. 273:1303–1308.
   PubMed Web of Science ®Google Scholar
• Vindis C, Teli T, Cerretti DP, Turner CE, Huynh-Do U. 2004. EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118. J. Biol. Chem. 279:27965–27970.
   PubMedGoogle Scholar
• Brantley-Sieders DM, Caughron J, Hicks D, Pozzi A, Ruiz JC, Chen J. 2004. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. J. Cell Sci. 117:2037–2049.
   PubMed Web of Science ®Google Scholar
• Miao H, Li DQ, Mukherjee A, Guo H, Petty A, Cutter J, Basilion JP, Sedor J, Wu J, Danielpour D, Sloan AE, Cohen ML, Wang B. 2009. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16:9–20.
   PubMed Web of Science ®Google Scholar
• Taddei ML, Parri M, Angelucci A, Onnis B, Bianchini F, Giannoni E, Raugei G, Calorini L, Rucci N, Teti A, Bologna M, Chiarugi P. 2009. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Am. J. Pathol. 174:1492–1503.
   PubMedGoogle Scholar
• Zhu JH, Chen R, Yi W, Cantin GT, Fearns C, Yang Y, Yates JRIII, Lee JD. 2008. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling. Oncogene 27:2525–2531.
   PubMedGoogle Scholar
• Yu M, Lin G, Arshadi N, Kalatskaya I, Xue B, Haider S, Nguyen F, Boutros PC, Elson A, Muthuswamy LB, Tonks NK, Muthuswamy SK. 2012. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation. Mol. Cell. Biol. 32:3913–3924.
   PubMedGoogle Scholar
• De Franceschi L, Biondani A, Carta F, Turrini F, Laudanna C, Deana R, Brunati AM, Turretta L, Iolascon A, Perrotta S, Elson A, Bulato C, Brugnara C. 2008. PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. Proteomics 8:4695–4708.
   PubMed Web of Science ®Google Scholar
• Su J, Muranjan M, Sap J. 1999. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr. Biol. 9:505–511.
   PubMed Web of Science ®Google Scholar
• Ponniah S, Wang DZ, Lim KL, Pallen CJ. 1999. Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Curr. Biol. 9:535–538.
   PubMedGoogle Scholar
• Zeng L, Si X, Yu WP, Le HT, Ng KP, Teng RM, Ryan K, Wang DZ, Ponniah S, Pallen CJ. 2003. PTP alpha regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration. J. Cell Biol. 160:137–146.
   PubMedGoogle Scholar
• Müller T, Choidas A, Reichmann E, Ullrich A. 1999. Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J. Biol. Chem. 274:10173–10183.
   PubMedGoogle Scholar
• Debant A, Serra-Pages C, Seipel K, O'Brien S, Tang M, Park SH, Streuli M. 1996. The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. Proc. Natl. Acad. Sci. U. S. A. 93:5466–5471.
   PubMed Web of Science ®Google Scholar
• Harrington RJ, Gutch MJ, Hengartner MO, Tonks NK, Chisholm AD. 2002. The C. elegans LAR-like receptor tyrosine phosphatase PTP-3 and the VAB-1 Eph receptor tyrosine kinase have partly redundant functions in morphogenesis. Development 129:2141–2153.
   PubMedGoogle Scholar